Cidofovir dihydrate

CAS: 149394-66-1

Ref. TM-T8736

Informação sobre produto

• Nome: Cidofovir dihydrate
• Sinónimos: HPMPC, (S)-HPMPC, GS 0504, ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid dihydrate, Cidofovir hydrate, Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, hydrate (1:2), Phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, Phosphonic acid, [[2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, (S)-, acide {[(1S)-2-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxyméthyl)éthoxy]méthyl}phosphonique dihydrate, phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, {[(1S)-2-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphons?uredihydrat, {[(1S)-2-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid dihydrate
• CAS: 149394-66-1

Descrição

Cidofovir dihydrate (HPMPC) is an anti-CMV drug, It can suppress CMV replication by selective inhibition of viral DNA polymerase and therefore prevention of viral replication and transcription. Cidofovir dihydrate is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis- an infection of the retina of the eye in people with AIDS

• Marca: Targetmol

Propriedades químicas

• Peso molecular: 315.22
• Fórmula: C₈H₁₈N₃O₈P
• Pureza: 99.97%
• Cor/forma: Solid